Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing.

CRyPTIC Consortium and the 100,000 Genomes Project, Allix-Béguec C, Arandjelovic I, Bi L, Beckert P, Bonnet M, Bradley P, Cabibbe AM, Cancino-Muñoz I, Caulfield MJ, Chaiprasert A, Cirillo DM, Clifton DA, Comas I, Crook DW, De Filippo MR, de Neeling H, Diel R, Drobniewski FA, Faksri K, Farhat MR, Fleming J, Fowler P, Fowler TA, Gao Q, Gardy J, Gascoyne-Binzi D, Gibertoni-Cruz AL, Gil-Brusola A, Golubchik T, Gonzalo X, Grandjean L, He G, Guthrie JL, Hoosdally S, Hunt M, Iqbal Z, Ismail N, Johnston J, Khanzada FM, Khor CC, Kohl TA, Kong C, Lipworth S, Liu Q, Maphalala G, Martinez E, Mathys V, Merker M, Miotto P, Mistry N, Moore DAJ, Murray M, Niemann S, Omar SV, Ong RT, Peto TEA, Posey JE, Prammananan T, Pym A, Rodrigues C, Rodrigues M, Rodwell T, Rossolini GM, Sánchez Padilla E, Schito M, Shen X, Shendure J, Sintchenko V, Sloutsky A, Smith EG, Snyder M, Soetaert K, Starks AM, Supply P, Suriyapol P, Tahseen S, Tang P, Teo YY, Thuong TNT, Thwaites G, Tortoli E, van Soolingen D, Walker AS, Walker TM, Wilcox M, Wilson DJ, Wyllie D, Yang Y, Zhang H, Zhao Y, Zhu B.

N Engl J Med. 2018 Oct 11;379(15):1403-1415. doi: 10.1056/NEJMoa1800474. Epub 2018 Sep 26.

2.

Resistance profile and risk factors of drug resistant tuberculosis in the Baltic countries.

Ignatyeva O, Balabanova Y, Nikolayevskyy V, Koshkarova E, Radiulyte B, Davidaviciene E, Riekstina V, Jaama K, Danilovits M, Popa CM, Drobniewski FA.

Tuberculosis (Edinb). 2015 Sep;95(5):581-8. doi: 10.1016/j.tube.2015.05.018. Epub 2015 Jun 24.

PMID:
26164355
3.

Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study.

Walker TM, Kohl TA, Omar SV, Hedge J, Del Ojo Elias C, Bradley P, Iqbal Z, Feuerriegel S, Niehaus KE, Wilson DJ, Clifton DA, Kapatai G, Ip CLC, Bowden R, Drobniewski FA, Allix-Béguec C, Gaudin C, Parkhill J, Diel R, Supply P, Crook DW, Smith EG, Walker AS, Ismail N, Niemann S, Peto TEA; Modernizing Medical Microbiology (MMM) Informatics Group.

Lancet Infect Dis. 2015 Oct;15(10):1193-1202. doi: 10.1016/S1473-3099(15)00062-6. Epub 2015 Jun 23. Erratum in: Lancet Infect Dis. 2017 Nov 21;:.

4.

Multidrug-resistant tuberculosis in the United Kingdom and Lithuania.

Gonzalo X, Hutchison DC, Drobniewski FA, Pimkina E, Davidaviciene E.

Int J Tuberc Lung Dis. 2014 Jun;18(6):663-5. doi: 10.5588/ijtld.13.0342.

PMID:
24903935
5.

Ethnic variation in inflammatory profile in tuberculosis.

Coussens AK, Wilkinson RJ, Nikolayevskyy V, Elkington PT, Hanifa Y, Islam K, Timms PM, Bothamley GH, Claxton AP, Packe GE, Darmalingam M, Davidson RN, Milburn HJ, Baker LV, Barker RD, Drobniewski FA, Mein CA, Bhaw-Rosun L, Nuamah RA, Griffiths CJ, Martineau AR.

PLoS Pathog. 2013;9(7):e1003468. doi: 10.1371/journal.ppat.1003468. Epub 2013 Jul 4.

6.

Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment.

Coussens AK, Wilkinson RJ, Hanifa Y, Nikolayevskyy V, Elkington PT, Islam K, Timms PM, Venton TR, Bothamley GH, Packe GE, Darmalingam M, Davidson RN, Milburn HJ, Baker LV, Barker RD, Mein CA, Bhaw-Rosun L, Nuamah R, Young DB, Drobniewski FA, Griffiths CJ, Martineau AR.

Proc Natl Acad Sci U S A. 2012 Sep 18;109(38):15449-54. Epub 2012 Sep 4.

7.

Risk factors for drug-resistant tuberculosis patients in Lithuania, 2002-2008.

Balabanova Y, Radiulyte B, Davidaviciene E, Hooper R, Ignatyeva O, Nikolayevskyy V, Drobniewski FA.

Eur Respir J. 2012 May;39(5):1266-9. doi: 10.1183/09031936.00133911. No abstract available.

8.

Rapid molecular detection of tuberculosis and rifampicin drug resistance: retrospective analysis of a national U.K. molecular service over the last decade.

Seoudi N, Mitchell SL, Brown TJ, Dashti F, Amin AK, Drobniewski FA.

Thorax. 2012 Apr;67(4):361-7. doi: 10.1136/thoraxjnl-2011-200610. Epub 2012 Jan 2.

PMID:
22213739
9.

Survival of drug resistant tuberculosis patients in Lithuania: retrospective national cohort study.

Balabanova Y, Radiulyte B, Davidaviciene E, Hooper R, Ignatyeva O, Nikolayevskyy V, Drobniewski FA.

BMJ Open. 2011 Nov 28;1(2):e000351. doi: 10.1136/bmjopen-2011-000351. Print 2011.

10.

Human Mycobacterium bovis infections in London and Southeast England.

Stone MJ, Brown TJ, Drobniewski FA.

J Clin Microbiol. 2012 Jan;50(1):164-5. doi: 10.1128/JCM.05692-11. Epub 2011 Nov 9.

11.

Survival of civilian and prisoner drug-sensitive, multi- and extensive drug- resistant tuberculosis cohorts prospectively followed in Russia.

Balabanova Y, Nikolayevskyy V, Ignatyeva O, Kontsevaya I, Rutterford CM, Shakhmistova A, Malomanova N, Chinkova Y, Mironova S, Fedorin I, Drobniewski FA.

PLoS One. 2011;6(6):e20531. doi: 10.1371/journal.pone.0020531. Epub 2011 Jun 10.

12.

High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial.

Martineau AR, Timms PM, Bothamley GH, Hanifa Y, Islam K, Claxton AP, Packe GE, Moore-Gillon JC, Darmalingam M, Davidson RN, Milburn HJ, Baker LV, Barker RD, Woodward NJ, Venton TR, Barnes KE, Mullett CJ, Coussens AK, Rutterford CM, Mein CA, Davies GR, Wilkinson RJ, Nikolayevskyy V, Drobniewski FA, Eldridge SM, Griffiths CJ.

Lancet. 2011 Jan 15;377(9761):242-50. doi: 10.1016/S0140-6736(10)61889-2. Epub 2011 Jan 5.

13.

Multidrug-resistant tuberculosis: resistance rates to first and reserve antituberculosis drugs in the UK in 2008/9 and the role of rapid molecular tests for drug resistance.

Mitchell SL, Seoudi N, Hutchison DC, Drobniewski FA.

Thorax. 2011 Jul;66(7):630-1. doi: 10.1136/thx.2010.148866. Epub 2010 Sep 29. No abstract available.

PMID:
20880876
14.

Typing Mycobacterium tuberculosis using variable number tandem repeat analysis.

Brown TJ, Nikolayevskyy VN, Drobniewski FA.

Methods Mol Biol. 2009;465:371-94. doi: 10.1007/978-1-59745-207-6_25.

PMID:
20560063
15.

The added value of a European Union tuberculosis reference laboratory network--analysis of the national reference laboratory activities.

Drobniewski FA, Nikolayevskyy V, Hoffner S, Pogoryelova O, Manissero D, Ozin AJ.

Euro Surveill. 2008 Mar 18;13(12). pii: 8076.

16.

Molecular epidemiology and prevalence of mutations conferring rifampicin and isoniazid resistance in Mycobacterium tuberculosis strains from the southern Ukraine.

Nikolayevskyy VV, Brown TJ, Bazhora YI, Asmolov AA, Balabanova YM, Drobniewski FA.

Clin Microbiol Infect. 2007 Feb;13(2):129-138. doi: 10.1111/j.1469-0691.2006.01583.x.

17.

Recommended standards for modern tuberculosis laboratory services in Europe.

Drobniewski FA, Hoffner S, Rusch-Gerdes S, Skenders G, Thomsen V; WHO European Laboratory Strengthening Task Force.

Eur Respir J. 2006 Nov;28(5):903-9. Epub 2006 Aug 9.

18.

Progression toward an improved DNA amplification-based typing technique in the study of Mycobacterium tuberculosis epidemiology.

Gopaul KK, Brown TJ, Gibson AL, Yates MD, Drobniewski FA.

J Clin Microbiol. 2006 Jul;44(7):2492-8.

20.

[Molecular typing of the Mycobacterium tuberculosis strains circulating in central Russia: efficiency of spoligotyping and VNTR-MIRU].

Nikolaevskiĭ VV, Balabanova IaM, Brown T, Drobniewski FA, Fedorin IM.

Mol Gen Mikrobiol Virusol. 2005;(4):9-14. Russian.

PMID:
16334218
21.

The use of macroarrays for the identification of MDR Mycobacterium tuberculosis.

Brown TJ, Herrera-Leon L, Anthony RM, Drobniewski FA.

J Microbiol Methods. 2006 May;65(2):294-300. Epub 2005 Sep 8.

PMID:
16153726
22.

Tuberculosis, HIV seroprevalence and intravenous drug abuse in prisoners.

Drobniewski FA, Balabanova YM, Ruddy MC, Graham C, Kuznetzov SI, Gusarova GI, Zakharova SM, Melentyev AS, Fedorin IM.

Eur Respir J. 2005 Aug;26(2):298-304.

23.

Molecular analysis of isoniazid-resistant Mycobacterium tuberculosis isolates from England and Wales reveals the phylogenetic significance of the ahpC -46A polymorphism.

Baker LV, Brown TJ, Maxwell O, Gibson AL, Fang Z, Yates MD, Drobniewski FA.

Antimicrob Agents Chemother. 2005 Apr;49(4):1455-64.

24.

[Mutations linked with antimicrobial resistance in Mycobacterium tuberculosis isolated from tuberculosis patients in the Samara region].

Nikolaevskiĭ VV, Drobniewski FA, Brown TJ, Balabanova IaM, Ruddy M, Fedorin IM, Bazhora IuI.

Zh Mikrobiol Epidemiol Immunobiol. 2005 Jan-Feb;(1):11-6. Russian.

PMID:
15773392
25.

[Molecular-genetic characteristics of Mycobacterium tuberculosis strains isolated in southern region of Ukraine].

Nikolaevskiĭ VV, Drobniewski FA, Bazhora IuI.

Tsitol Genet. 2004 Jul-Aug;38(4):23-8. Russian.

PMID:
15715161
26.

Mycobacterium tuberculosis Beijing genotype, northern Malawi.

Glynn JR, Crampin AC, Traore H, Yates MD, Mwaungulu FD, Ngwira BM, Chaguluka SD, Mwafulirwa DT, Floyd S, Murphy C, Drobniewski FA, Fine PE.

Emerg Infect Dis. 2005 Jan;11(1):150-3.

27.

Explaining risk factors for drug-resistant tuberculosis in England and Wales: contribution of primary and secondary drug resistance.

Conaty SJ, Hayward AC, Story A, Glynn JR, Drobniewski FA, Watson JM.

Epidemiol Infect. 2004 Dec;132(6):1099-108.

28.

The 'bear trap': the colliding epidemics of tuberculosis and HIV in Russia.

Drobniewski FA, Atun R, Fedorin I, Bikov A, Coker R.

Int J STD AIDS. 2004 Oct;15(10):641-6. Review.

PMID:
15479497
29.

DNA fingerprint changes in tuberculosis: reinfection, evolution, or laboratory error?

Glynn JR, Yates MD, Crampin AC, Ngwira BM, Mwaungulu FD, Black GF, Chaguluka SD, Mwafulirwa DT, Floyd S, Murphy C, Drobniewski FA, Fine PE.

J Infect Dis. 2004 Sep 15;190(6):1158-66. Epub 2004 Aug 3.

PMID:
15319867
30.

Outbreak of isoniazid resistant tuberculosis in north London.

Ruddy MC, Davies AP, Yates MD, Yates S, Balasegaram S, Drabu Y, Patel B, Lozewicz S, Sen S, Bahl M, James E, Lipman M, Duckworth G, Watson JM, Piper M, Drobniewski FA, Maguire H.

Thorax. 2004 Apr;59(4):279-85.

31.

Molecular epidemiology of disease due to Mycobacterium bovis in humans in the United Kingdom.

Gibson AL, Hewinson G, Goodchild T, Watt B, Story A, Inwald J, Drobniewski FA.

J Clin Microbiol. 2004 Jan;42(1):431-4.

33.

Modern laboratory diagnosis of tuberculosis.

Drobniewski FA, Caws M, Gibson A, Young D.

Lancet Infect Dis. 2003 Mar;3(3):141-7. Review.

PMID:
12614730
34.

Use of a phage-based assay for phenotypic detection of mycobacteria directly from sputum.

Park DJ, Drobniewski FA, Meyer A, Wilson SM.

J Clin Microbiol. 2003 Feb;41(2):680-8.

35.

Management of multiple drug-resistant tuberculosis.

Hutchison DC, Drobniewski FA, Milburn HJ.

Respir Med. 2003 Jan;97(1):65-70.

36.

Molecular epidemiology of tuberculosis in London 1995-7 showing low rate of active transmission.

Maguire H, Dale JW, McHugh TD, Butcher PD, Gillespie SH, Costetsos A, Al-Ghusein H, Holland R, Dickens A, Marston L, Wilson P, Pitman R, Strachan D, Drobniewski FA, Banerjee DK.

Thorax. 2002 Jul;57(7):617-22.

37.

The diagnosis and management of multiple-drug-resistant-tuberculosis at the beginning of the new millenium.

Drobniewski FA, Balabanova YM.

Int J Infect Dis. 2002 Mar;6 Suppl 1:S21-31. Review.

38.
39.

Molecular techniques in the diagnosis of Mycobacterium tuberculosis and the detection of drug resistance.

Caws M, Drobniewski FA.

Ann N Y Acad Sci. 2001 Dec;953:138-45. Review.

PMID:
11795406
40.

Multiple-drug-resistant tuberculosis.

Drobniewski FA.

Lancet. 2000 Dec;356 Suppl:s62. No abstract available.

PMID:
11191522
41.

Tuberculosis and the role of war in the modern era.

Drobniewski FA, Verlander NQ.

Int J Tuberc Lung Dis. 2000 Dec;4(12):1120-5.

PMID:
11144453
42.

Issues facing TB control (5.1). (b). Diagnostic issues: molecular technology in the diagnosis and treatment of tuberculosis.

Drobniewski FA.

Scott Med J. 2000 Oct;45(5 Suppl):40-2; discussion 43. Review. No abstract available.

PMID:
11130315
43.

Modern laboratory diagnosis of mycobacterial infections.

Watterson SA, Drobniewski FA.

J Clin Pathol. 2000 Oct;53(10):727-32. Review.

44.

Surveillance of drug-resistant tuberculosis and molecular evaluation of transmission of resistant strains in refugee and non-refugee populations in North-Eastern Kenya.

Githui WA, Hawken MP, Juma ES, Godfrey-Faussett P, Swai OB, Kibuga DK, Porter JD, Wilson SM, Drobniewski FA.

Int J Tuberc Lung Dis. 2000 Oct;4(10):947-55.

PMID:
11055762
47.

A national audit of the laboratory diagnosis of tuberculosis and other mycobacterial diseases within the United Kingdom.

Drobniewski FA, Watt B, Smith EG, Magee JG, Williams R, Holder J, Ostrowski J.

J Clin Pathol. 1999 May;52(5):334-7.

49.
50.

Molecular epidemiology of Mycobacterium avium complex isolated from patients with and without AIDS in Brazil and England.

Telles MA, Yates MD, Curcio M, Ueki SY, Palaci M, Hadad DJ, Drobniewski FA, Pozniak AL.

Epidemiol Infect. 1999 Jun;122(3):435-40.

Supplemental Content

Loading ...
Support Center